Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Effects of Psilocybin in Major Depressive Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03181529

Organisation Name: Johns Hopkins University

Overal Status: Active, not recruiting

Start Date: August 10, 2017

Last Update: December 27, 2019

Lead Sponsor: Johns Hopkins University

Brief Summary: The proposed pilot study will assess whether people with major depressive disorder experience psychological and behavioral benefits and/or harms from psilocybin. This study will investigate acute and persisting effects of psilocybin on depressive symptoms and other moods, attitudes, and behaviors. The primary hypothesis is that psilocybin will lead to rapid and sustained antidepressant response, as measured with standard depression rating scales.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.15583896636963